• Milan court revoked a June 12 preliminary order that had suspended a bylaw change expanding the company’s corporate purpose.
• The July 9 order restored the amendment’s full effect; the decision was notified to the company on July 13.
• Judges found the company’s interest outweighed alleged harm to plaintiffs, citing prior investment commitments and strategic importance.
• The court ordered removal of the suspension entry from Italy’s Companies Register.
• The underlying shareholder lawsuit challenging the May 2, 2024 and Oct. 29, 2025 resolutions remains pending in Milan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033176), on July 14, 2026, and is solely responsible for the information contained therein.